Literature DB >> 18758473

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.

György Haskó1, Joel Linden, Bruce Cronstein, Pál Pacher.   

Abstract

Adenosine is a key endogenous molecule that regulates tissue function by activating four G-protein-coupled adenosine receptors: A1, A2A, A2B and A3. Cells of the immune system express these receptors and are responsive to the modulatory effects of adenosine in an inflammatory environment. Animal models of asthma, ischaemia, arthritis, sepsis, inflammatory bowel disease and wound healing have helped to elucidate the regulatory roles of the various adenosine receptors in dictating the development and progression of disease. This recent heightened awareness of the role of adenosine in the control of immune and inflammatory systems has generated excitement regarding the potential use of adenosine-receptor-based therapies in the treatment of infection, autoimmunity, ischaemia and degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758473      PMCID: PMC2568887          DOI: 10.1038/nrd2638

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  130 in total

1.  Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis.

Authors:  Gideon Nesher; Michal Mates; Shoshana Zevin
Journal:  Arthritis Rheum       Date:  2003-02

2.  Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.

Authors:  E S L Chan; P Fernandez; A A Merchant; M C Montesinos; S Trzaska; A Desai; C F Tung; D N Khoa; M H Pillinger; A B Reiss; M Tomic-Canic; J F Chen; M A Schwarzschild; B N Cronstein
Journal:  Arthritis Rheum       Date:  2006-08

3.  Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage.

Authors:  M Mayne; J Fotheringham; H J Yan; C Power; M R Del Bigio; J Peeling; J D Geiger
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

Review 4.  Shaping of monocyte and macrophage function by adenosine receptors.

Authors:  György Haskó; Pál Pacher; Edwin A Deitch; E Sylvester Vizi
Journal:  Pharmacol Ther       Date:  2006-09-14       Impact factor: 12.310

5.  Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.

Authors:  C A Salvatore; S L Tilley; A M Latour; D S Fletcher; B H Koller; M A Jacobson
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

6.  A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis.

Authors:  George Gallos; Thomas D Ruyle; Charles W Emala; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2005-03-22

Review 7.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

8.  Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

Authors:  J P diMarco; T D Sellers; B B Lerman; M L Greenberg; R M Berne; L Belardinelli
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

Review 9.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

10.  Enhanced mast cell activation in mice deficient in the A2b adenosine receptor.

Authors:  Xiaoyang Hua; Martina Kovarova; Kelly D Chason; MyTrang Nguyen; Beverly H Koller; Stephen L Tilley
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

View more
  469 in total

1.  Adenosine 2a Receptor Signal Blockade of Murine Autoimmune Arthritis via Inhibition of Pathogenic Germinal Center-Follicular Helper T Cells.

Authors:  Shirdi E Schmiel; Lokesh A Kalekar; Na Zhang; Thomas W Blankespoor; Londyn J Robinson; Daniel L Mueller
Journal:  Arthritis Rheumatol       Date:  2019-03-25       Impact factor: 10.995

Review 2.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

3.  Anti-inflammatory or proinflammatory effect of an adenosine receptor agonist on the Th17 autoimmune response is inflammatory environment-dependent.

Authors:  Dongchun Liang; Aijun Zuo; Hui Shao; Mingjiazi Chen; Henry J Kaplan; Deming Sun
Journal:  J Immunol       Date:  2014-11-03       Impact factor: 5.422

4.  Purinergic signaling: a fundamental mechanism in neutrophil activation.

Authors:  Yu Chen; Yongli Yao; Yuka Sumi; Andrew Li; Uyen Kim To; Abdallah Elkhal; Yoshiaki Inoue; Tobias Woehrle; Qin Zhang; Carl Hauser; Wolfgang G Junger
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

5.  Emerging adenosine receptor agonists: an update.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Expert Opin Emerg Drugs       Date:  2011-12-07       Impact factor: 4.191

Review 6.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

7.  Deconstructing tick saliva: non-protein molecules with potent immunomodulatory properties.

Authors:  Carlo José F Oliveira; Anderson Sá-Nunes; Ivo M B Francischetti; Vanessa Carregaro; Elen Anatriello; João S Silva; Isabel K F de Miranda Santos; José M C Ribeiro; Beatriz R Ferreira
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

8.  Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.

Authors:  Michel Fausther; Joanna Lecka; Elwy Soliman; Gilles Kauffenstein; Julie Pelletier; Nina Sheung; Jonathan A Dranoff; Jean Sévigny
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-01       Impact factor: 4.052

Review 9.  The role of adenosine signaling in sickle cell therapeutics.

Authors:  Joshua J Field; David G Nathan; Joel Linden
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

10.  Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells.

Authors:  Yuliia Kaljas; Chengqian Liu; Maksym Skaldin; Chengxiang Wu; Qing Zhou; Yuanan Lu; Ivona Aksentijevich; Andrey V Zavialov
Journal:  Cell Mol Life Sci       Date:  2016-09-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.